c-myc Reverses neu-induced Transformed Morphology by Transcriptional Repression

References

• Adnane, J., P. Gaudray, M.-P. Simon, J. Simony-Lafontaine, P. Jeanteur, and C. Theillet. 1989. Proto-oncogene amplification and human breast tumor phenotype. Oncogene 4:1389–1395.
   PubMed Web of Science ®Google Scholar
• Akiyama, T., C. Sudo, H. Ogawara, K. Toyoshima, and T. Yamamoto. 1986. The product of the human c-erb.-2 gene: a 185 kilodalton glycoprotein with tyrosine kinase activity. Science 232:1644–1646.
   PubMed Web of Science ®Google Scholar
• Alitalo, K., P. Koskinen, T. P. Makela, K. Saksela, L. Sistonen, and R. Winqvist. 1987. my. oncogenes: activation and amplification. Biochim. Biophys. Acta 907:1–32.
   PubMed Web of Science ®Google Scholar
• Ariga, H., Y. Imamura, and S. M. M. Iguchi-Ariga. 1989. DNA replication origin and transcriptional enhancer in c-my. gene share the c-myc protein binding sequence. EMBO J. 8:4273–4279.
   PubMedGoogle Scholar
• Bargmann, C. I., M.-C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the ne. oncogene by a point mutation altering the transmembrane domain of pl85. Cell 45:649–657.
   PubMed Web of Science ®Google Scholar
• Bargmann, C. I., M.-C. Hung, and R. A. Weinberg. 1986. The ne. oncogene encodes an epidermal growth factor receptor related protein. Nature (London) 319:226–230.
   PubMed Web of Science ®Google Scholar
• Bargmann, C. I., and R. A. Weinberg. 1988. Oncogenic activation of the ne. encoded receptor protein by point mutation and deletion. EMBO J. 7:2043–2052.
   PubMed Web of Science ®Google Scholar
• Bargmann, C. I., and R. A. Weinberg. 1988. Increased tyrosine kinase activity associated with the protein encoded by the activated ne. oncogene. Proc. Natl. Acad. Sci. USA 85:5394–5398.
   PubMed Web of Science ®Google Scholar
• Bernards, R., S. K. Dessain, and R. A. Weinberg. 1986. N-my. amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 57:931–936.
   Google Scholar
• Bouchard, L., L. Lamarre, P. J. Tremblay, and P. Jolicoeur. 1989. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV7c-ne.. Cell 57:931–936.
   PubMed Web of Science ®Google Scholar
• Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
   PubMed Web of Science ®Google Scholar
• Cleveland, J. L., M. Huleihei, P. Bressler, U. Siebenlist, L. Akiyama, R. N. Eisenman, and U. R. Rapp. 1988. Negative regulation of c-my. transcription involves my. family proteins. Oncogene Res. 3:357–375.
   PubMedGoogle Scholar
• Cole, M. D. 1986. The my. oncogene: its role in transformation and differentiation. Annu. Rev. Genet. 20:361–384.
   PubMed Web of Science ®Google Scholar
• Coughlin, S. R., W. M. F. Lee, P. W. Williams, G. M. Giels, and L. T. Williams. 1985. c-my. gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF. Cell 43:243–251.
   PubMed Web of Science ®Google Scholar
• Coussens, L., T. L. Yang-Feng, Y.-C. Liao, C. Chen, A. Gray, J. McGarth, P. H. Seeburg, T. A. Libermann, J. Schlessinger, U. Francke, A. Levinson, and A. Ullrich. 1985. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with ne. oncogene. Science 230:1132–1139.
   PubMed Web of Science ®Google Scholar
• Dang, C. V., H. van Dam, M. Buckmire, and W. M. F. Lee. 1989. DNA-binding domain of human c-my. produced in Escherichia coli. Mol. Cell. Biol. 9:2477–2486.
   Google Scholar
• Di Fiore, P. P., J. H. Pierce, M. H. Kraus, O. Segatto, C. R. King, and S. A. Aaronson. 1987. erbB.2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237:178–182.
   PubMedGoogle Scholar
• Dignam, J. D., R. M. Leibovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Dugaiczyk, A., J. A. Haron, E. M. Stone, E. Dennison, K. N. Rothblum, and R. J. Schwartz. 1983. Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. Biochemistry 22:1605–1613.
   PubMed Web of Science ®Google Scholar
• Edlund, T., M. D. Walker, B. J. Barr, and W. J. Ratter. 1985. Cell specific expression of the rat insulin gene: evidence for role of two distinct 5′ flanking elements. Science 230:912–926.
   PubMed Web of Science ®Google Scholar
• Garcia, G., P.-Y. Dietrich, M. Aapro, G. Vauthier, L. Vadas, and E. Engel. 1987. Genetic alterations of c-myc. c-erbB.2, and c-Ha-ra. proto-oncogenes and clinical associations in human breast carcinomas. Cancer Res. 49:6675–6679.
   Google Scholar
• Gorman, C. M., G. T. Merlino, M. C. William, I. Pastan, and B. H. Howard. 1982. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA mediated transfection. Proc. Natl. Acad. Sci. USA 79:6777–6781.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Guerin, M., M. Baross, M.-J. Terrier, M. Spielmann, and G. Riou. 1988. Overexpression of either c-my. or c-erbB-2/ne. proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res. 3:21–31.
   PubMedGoogle Scholar
• Hudziak, R. M., J. Schlessinger, and A. Ullrich. 1987. Increased expression of the putative growth factor receptor p185 HER2 causes transformation and tumorigenesis of NIH3T3 cells. Proc. Natl. Acad. Sci. USA 84:7159–7163.
   PubMed Web of Science ®Google Scholar
• Hung, M.-C., A. L. Schechter, P. M. Chevray, D. F. Stern, and R. A. Weinberg. 1986. Molecular cloning of the ne. gene: absence of gross structural alteration in oncogenic alleles. Proc. Natl. Acad. Sci. USA 83:2611–2614.
   Google Scholar
• Iguchi-Ariga, S. M. M., T. Itani, Y. Kiji, and H. Ariga. 1987. Possible function of the c-my. product: promotion of cellular DNA replication. EMBO J. 6:2365–2371.
   PubMed Web of Science ®Google Scholar
• Iguchi-Ariga, S. M. M., T. Okazaki, T. Itani, M. Ogata, Y. Sato, and H. Ariga. 1988. An initiation site of DNA replication with transcriptional enhancer activity present upstream of the c-my. gene. EMBO J. 7:3135–3142.
   PubMedGoogle Scholar
• Ishii, S., Y.-H. Su, R. H. Stratton, B. A. Roe, G. T. Merlino, and I. Pastan. 1985. Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. USA 82:4920–4924.
   PubMedGoogle Scholar
• Johnson, A. C., S. Ishii, Y. Jinno, I. Pastan, and G. T. Merlino. 1988. Epidermal growth factor receptor gene promoter. Deletion analysis and identification of nuclear protein binding sites. J. Biol. Chem. 263:5693–5699.
   Google Scholar
• Johnson, A. C., Y. Jinno, and G. T. Merlino. 1988. Modulation of epidermal growth factor receptor proto-oncogene transcription by a promoter site sensitive to SI nuclease. Mol. Cell. Biol. 8:4174–4184.
   PubMed Web of Science ®Google Scholar
• Kageyama, R., G. T. Merlino, and I. Pastan. 1988. Epidermal growth factor receptor gene transcription. Requirement for Sp1 and an EGF receptor-specific factor. J. Biol. Chem. 263:6329–6336.
   Google Scholar
• Kageyama, R., G. T. Merlino, and I. Pastan. 1988. A transcription factor active on the epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. USA 85:5016–5020.
   PubMedGoogle Scholar
• Keath, E. J., P. G. Caimi, and M. D. Cole. 1984. Fibroblast lines expressing activated c-my. oncogenes are tumorigenic in nude mice and syngeneic animals. Cell 39:339–348.
   PubMed Web of Science ®Google Scholar
• Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell specific regulation of the c-my. gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610.
   PubMed Web of Science ®Google Scholar
• King, C. R., M. H. Kraus, and S. A. Aaronson. 1985. Amplification of a novel v-erb.-related gene in a human mammary carcinoma. Science 229:974–976.
   PubMed Web of Science ®Google Scholar
• Kingston, R. E., A. S. Baldwin, Jr., and P. A. Sharp. 1984. Regulation of heat shock protein 70 gene expression by c-myc. Nature (London) 312:280–282.
   PubMed Web of Science ®Google Scholar
• Kokai, Y., J. N. Myers, T. Wada, V. I. Brown, C. M. LeVea, J. G. Davis, K. Dobashi, and M. I. Greene. 1989. Synergistic interaction of p185c-ne. and the EGF recepter leads to transformation of rodent fibroblasts. Cell 58:287–292.
   PubMed Web of Science ®Google Scholar
• Kozobor, D., and C. M. Croce. 1984. Amplification of c-my. oncogene in one of five human breast carcinoma cell lines. Cancer Res. 44:438–441.
   PubMedGoogle Scholar
• Kraus, M. H., N. C. Popescu, S. C. Amsbaugh, and C. R. King. 1987. Overexpression of the EGF receptor-related proto-oncogene erbB-. in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 6:605–610.
   PubMed Web of Science ®Google Scholar
• Land, H., A. C. Chen, J. P. Morgenstern, L. F. Parada, and R. A. Weinberg. 1986. Behavior of my. and ra. oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. Biol. 6:1917–1925.
   PubMed Web of Science ®Google Scholar
• Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (London) 304:596–602.
   PubMed Web of Science ®Google Scholar
• Lassar, A. B., J. N. Buskin, D. Lockshon, R. L. Davis, S. Apone, S. D. Hauschka, and H. Weintraub. 1989. MyoD is a sequencespecific DNA binding protein requiring a region of my. homology to bind to muscle creatine kinase enhancer. Cell 58:823–831.
   PubMedGoogle Scholar
• Leder, A., P. K. Pattengale, A. Kuo, T. A. Stewart, and P. Leder. 1986. Consequences of widespread deregulation of the c-my. gene in transgenic mice: multiple neoplasms and normal development. Cell 45:485–495.
   PubMed Web of Science ®Google Scholar
• Lenardo, M., A. K. Rustgi, A. R. Schievella, and R. Bernards. 1989. Suppression of MHC class I gene expression by N-my. through enhancer inactivation. EMBO J. 8:3351–3355.
   PubMed Web of Science ®Google Scholar
• Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Muller, W. J., E. Sinn, P. K. Pattengale, R. Wallace, and P. Leder. 1988. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-ne. oncogene. Cell 54:105–115.
   PubMed Web of Science ®Google Scholar
• Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD. and my. proteins. Cell 56:777–783.
   PubMed Web of Science ®Google Scholar
• Norton, P. A., and J. M. Coffin. 1985. Bacterial β-galactosidase as a marker gene of Rous sarcoma virus gene expression and replication. Mol. Cell. Biol. 5:281–290.
   PubMedGoogle Scholar
• Penn, L. J. Z., M. W. Brooks, E. M. Laufer, and H. Land. 1990. Negative autoregulation of c-my. transcription. EMBO J. 9:1113–1121.
   PubMed Web of Science ®Google Scholar
• Schwab, M., and L. C. Amler. 1990. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosomes Cancer 1:181–193.
   PubMed Web of Science ®Google Scholar
• Semba, K., K. Kamata, and T. Yamamoto. 1985. A v-erbB. related protooncogene, c-erb.-2 is distinct from the c-erb.-1/. epidermal growth factor receptor gene and is amplified in human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. USA 82:6497–6501.
   PubMed Web of Science ®Google Scholar
• Shih, C., L. C. Padhy, M. Murray, and R. A. Weinberg. 1981. Transformation gene of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature (London) 290:261–264.
   PubMed Web of Science ®Google Scholar
• Stem, D. F., P. A. Heffernan, and R. A. Weinberg. 1986. pl85, product of the ne. proto-oncogene, is a receptorlike protein associated with tryosine kinase activity. Mol. Cell. Biol. 6:1729–1740.
   PubMedGoogle Scholar
• Suda, Y., S. Aizawa, Y. Furuta, T. Yagi, Y. Ikawa, K. Saitoh, Y. Yamada, K. Toyoshima, and T. Yamamoto. 1990. Indication of a variety of tumors by c-erbB . and clonal nature of lymphomas even with the mutated gene (Val659-Glu659). EMBO J. 9:181–190.
   PubMed Web of Science ®Google Scholar
• Suen, T.-C., and M.-C. C. 1990. Multiple cis. and transacting elements involved in the regulation of the ne. gene. Mol. Cell. Biol. 10:6306–6315.
   PubMedGoogle Scholar
• Varley, J. M., J. E. Swallow, W. J. Brammar, J. L. Whittaker, and R. A. Walker. 1987. Alterations to either c-erbB-2 (neu. or c-my. proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene 1:423–430.
   PubMed Web of Science ®Google Scholar
• Varmus, H. E. 1987. Oncogene and transcriptional control. Science 238:1337–1339.
   PubMed Web of Science ®Google Scholar
• Watt, R. A., A. R. Shatzman, and M. Rosenberg. 1985. Expression and characterization of the human c-my. DNA binding protein. Mol. Cell. Biol. 5:448–456.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1985. The action of oncogenes in the cytoplasm and nucleus. Science 230:770–776.
   PubMed Web of Science ®Google Scholar
• Yamamoto, T., S. Ikawa, T. Akiyama, K. Semba, N. Nomura, N. Miyajima, T. Saito, and K. Toyoshima. 1986. Similarity of protein encoded by the human c-erbB-. gene to the epidermal growth factor receptor. Nature (London) 319:230–234.
   PubMed Web of Science ®Google Scholar
• Yarden, Y., and A. Ullrich. 1988. Growth factor receptor tyrosine kinase. Annu. Rev. Biochem. 57:443–478.
   PubMed Web of Science ®Google Scholar
• Yarden, Y., and R. A. Weinberg. 1989. Experimental approaches to hypothetical hormones: detection of a candidate ligand of the ne. protooncogene. Proc. Natl. Acad. Sci. USA 86:3179–3183.
   PubMed Web of Science ®Google Scholar
• Zenke, M., T. Grundstrom, H. Matthews, M. Wimtzerith, C. Shatz, A. Wildermann, and P. Chambon. 1986. Multiple sequence motifs are involved in SV40 enhancer function. EMBO J. 5:387–397.
   PubMed Web of Science ®Google Scholar